Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05302999 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 6 more changesShow less
    • Final enrollment: 26 participants (planned 42)
    • Primary completion date changed from estimate of Aug 31, 2026 to Mar 10, 2026
    • Study completion date changed from estimate of Aug 31, 2026 to Mar 31, 2026
    • Eligibility criteria expanded, about 8 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Re-verified, no change to tracked fieldsv6
  3. Site contact updatedv5
  4. Re-verified, no change to tracked fieldsv4
  5. Site contact updatedv3
  6. Primary and study completion dates: Aug 2026 to Aug 31, 2026v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.
Trial Details
NCT Number NCT05302999
Lead Sponsor MetroHealth Medical Center
Collaborators: National Institute on Disability, Independent Living, and Rehabilitation Research
Conditions
(from sponsor)		 Spinal Cord Injuries
Related terms Spinal Cord Injuries
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov